Article Details
Retrieved on: 2021-01-04 12:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's two non-inferiority trials met their main goals, showing that that faricimab given every eight weeks and at personalised dosing intervals of up to ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here